Literature DB >> 7679401

Ribotype analysis of Pseudomonas pseudomallei isolates.

M M Sexton1, L A Goebel, A J Godfrey, W Choawagul, N J White, D E Woods.   

Abstract

No epidemiological typing system to differentiate among Pseudomonas pseudomallei isolates has been available. Ribotype analysis was developed and used to examine 74 clinical and 10 environmental isolates of P. pseudomallei from Thailand. Six P. pseudomallei ribotypes were identified from restriction fragment polymorphisms of EcoRI chromosomal digests. The predominant ribotype, A, was found in 59 of the isolates examined. By using patterns from hybridizations with SalI, HindIII, and PstI restriction digests, isolates of ribotype A were subdivided into a further five subtypes, giving a total of 10 differentiable P. pseudomallei types. In 23 of 34 melioidosis patients studied, multiple P. pseudomallei isolates were present. In all but one of these patients, a single ribotype of the organism was present. Isolation of two different ribotypes of P. pseudomallei from one patient, one each in sputum and urine, suggests that superinfection may have occurred. The ribotype was shown to be conserved during the course of antibiotic treatments in seven patients studied, although the antibiotic sensitivity patterns in the isolates from these patients varied. The prevalence of subtype A1 in clinical and environmental specimens suggests that this strain may be predominant in this geographical location. These results demonstrate the usefulness of the ribotyping method for epidemiological studies of P. pseudomallei.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7679401      PMCID: PMC262742          DOI: 10.1128/jcm.31.2.238-243.1993

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  16 in total

1.  Melioidosis: recrudescence associated with bronchogenic carcinoma twenty-six years following initial geographic exposure.

Authors:  E E Mays; E A Ricketts
Journal:  Chest       Date:  1975-08       Impact factor: 9.410

Review 2.  Coagulase-negative staphylococci and the epidemiological typing of Staphylococcus epidermidis.

Authors:  J T Parisi
Journal:  Microbiol Rev       Date:  1985-06

3.  A broad-spectrum probe for molecular epidemiology of bacteria: ribosomal RNA.

Authors:  T L Stull; J J LiPuma; T D Edlind
Journal:  J Infect Dis       Date:  1988-02       Impact factor: 5.226

4.  Ribotype analysis of Pseudomonas cepacia from cystic fibrosis treatment centers.

Authors:  J J LiPuma; J E Mortensen; S E Dasen; T D Edlind; D V Schidlow; J L Burns; T L Stull
Journal:  J Pediatr       Date:  1988-11       Impact factor: 4.406

5.  Antibiotic resistance in Pseudomonas pseudomallei.

Authors:  D A Dance; V Wuthiekanun; N J White; W Chaowagul
Journal:  Lancet       Date:  1988-04-30       Impact factor: 79.321

6.  Ribotype stability of serial pulmonary isolates of Pseudomonas cepacia.

Authors:  J J LiPuma; M C Fisher; S E Dasen; J E Mortensen; T L Stull
Journal:  J Infect Dis       Date:  1991-07       Impact factor: 5.226

7.  Melioidosis: a major cause of community-acquired septicemia in northeastern Thailand.

Authors:  W Chaowagul; N J White; D A Dance; Y Wattanagoon; P Naigowit; T M Davis; S Looareesuwan; N Pitakwatchara
Journal:  J Infect Dis       Date:  1989-05       Impact factor: 5.226

8.  Cloning and expression in Pseudomonas aeruginosa of a gene involved in the production of alginate.

Authors:  J B Goldberg; D E Ohman
Journal:  J Bacteriol       Date:  1984-06       Impact factor: 3.490

9.  Typing of Pseudomonas cepacia by bacteriocin susceptibility and production.

Authors:  J R Govan; G Harris
Journal:  J Clin Microbiol       Date:  1985-10       Impact factor: 5.948

10.  Characterization and use of a DNA probe as an epidemiological marker for Pseudomonas aeruginosa.

Authors:  J W Ogle; J M Janda; D E Woods; M L Vasil
Journal:  J Infect Dis       Date:  1987-01       Impact factor: 7.759

View more
  10 in total

1.  Isolation of polymyxin B-susceptible mutants of Burkholderia pseudomallei and molecular characterization of genetic loci involved in polymyxin B resistance.

Authors:  M N Burtnick; D E Woods
Journal:  Antimicrob Agents Chemother       Date:  1999-11       Impact factor: 5.191

2.  Recurrent melioidosis: possible role of infection with multiple strains of Burkholderia pseudomallei.

Authors:  Tyrone L Pitt; Suwanna Trakulsomboon; David A B Dance
Journal:  J Clin Microbiol       Date:  2006-12-20       Impact factor: 5.948

3.  Ribotyping for use in studying molecular epidemiology of Serratia marcescens: comparison with biotyping.

Authors:  H Chetoui; E Delhalle; P Osterrieth; D Rousseaux
Journal:  J Clin Microbiol       Date:  1995-10       Impact factor: 5.948

4.  Subdivision of Burkholderia pseudomallei ribotypes into multiple types by random amplified polymorphic DNA analysis provides new insights into epidemiology.

Authors:  A Haase; H Smith-Vaughan; A Melder; Y Wood; A Janmaat; J Gilfedder; D Kemp; B Currie
Journal:  J Clin Microbiol       Date:  1995-07       Impact factor: 5.948

5.  Intracellular survival of Burkholderia pseudomallei.

Authors:  A L Jones; T J Beveridge; D E Woods
Journal:  Infect Immun       Date:  1996-03       Impact factor: 3.441

6.  Comparison of rapid, automated ribotyping and DNA macrorestriction analysis of Burkholderia pseudomallei.

Authors:  Timothy J J Inglis; Lyn O'Reilly; Niki Foster; Adele Clair; Judy Sampson
Journal:  J Clin Microbiol       Date:  2002-09       Impact factor: 5.948

7.  Interaction of insulin with Pseudomonas pseudomallei.

Authors:  D E Woods; A L Jones; P J Hill
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

8.  Isolation and characterization of Pseudomonas pseudomallei flagellin proteins.

Authors:  P J Brett; D C Mah; D E Woods
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

9.  Identification of melioidosis outbreak by multilocus variable number tandem repeat analysis.

Authors:  Bart J Currie; Asha Haslem; Talima Pearson; Heidie Hornstra; Benjamin Leadem; Mark Mayo; Daniel Gal; Linda Ward; Daniel Godoy; Brian G Spratt; Paul Keim
Journal:  Emerg Infect Dis       Date:  2009-02       Impact factor: 6.883

10.  Using BOX-PCR to exclude a clonal outbreak of melioidosis.

Authors:  Bart J Currie; Daniel Gal; Mark Mayo; Linda Ward; Daniel Godoy; Brian G Spratt; John J LiPuma
Journal:  BMC Infect Dis       Date:  2007-06-30       Impact factor: 3.090

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.